The latest biotech news

News and Trends 15 Dec 2016

10 Awesome Biotech Gifts for you and your Geekiest Loved Ones

Stuck on what to get your family and friends for Christmas? What about portable lab equipment or a stuffed version of your favorite microorganism? Biotech is one of the fastest growing sectors worldwide and a big employer in Europe. Providing solutions to cure, feed and fuel the world, who wouldn’t want to brag about this amazing field? Whether […]

December 15, 2016 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 14 Dec 2016

Deloitte’s Message to Pharma: Learn from Biotech or Perish

The consulting firm’s annual financial report suggests pharma’s current model is not sustainable. The solution? Be more like biotech. Pharma has had a rollercoaster of a year, from anxiety about the US election to stellar CAR-T results after patient deaths. Overall, however, the numbers have not been great, and a new report from the analysts at […]

December 14, 2016 - 2 minutesmins - By Evelyn Warner

News and Trends 14 Dec 2016

Liquid Biopsies: Lowering the Defenses of Resistant Lung Cancer

In response to new treatments, cancer came back stronger and more resistant than ever. Medicine’s counterattack will be more effective with a clear target. How do you solve a problem like drug resistance in cancer research? There’s no clear-cut answer yet, not least because the disease can vary so widely. But there has been some […]

December 14, 2016 - 4 minutesmins - By External Contributor

News and Trends 14 Dec 2016

Swedish Therapy targeting All Solid Tumors enrolls First Patient

Immunicum just received FDA approval to start clinical trials in the US for a therapy that could overcome the challenges of T-cell therapies and target virtually any injectable solid tumor. Immunicum is a biotech from Gothenburg, Sweden, that focuses on immuno-oncology with a different approach from most companies. Instead of T-cells, the company engineers dendritic […]

December 14, 2016 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 14 Dec 2016

UPDATE: Bayer seals deal with Monsanto in Dark Side slide

Bloomberg reports that Bayer has increased its bid once more to acquire the world’s least ethical company in order to solidify its position in agrochemicals. Bayer appears hell-bent on a Faustian bargain with Monsanto: the German chemical company has just thrown more money at America’s fourth most hated company in the hope of acquiring it. Despite its […]

December 14, 2016 - 3 minutesmins - By Evelyn Warner

News and Trends 14 Dec 2016

What do the CAR-T Patient Deaths Mean for the Future of the Field?

Juno’s JCAR015 study came to a halt for the second time this year after two more patient deaths. But despite the bad news, hopes for CAR-T therapies remain high. Juno Therapeutics again came under scrutiny last month following deaths in its JCAR015 trial. Two patients died from neurotoxicity-triggered cerebral edema, the same condition that killed […]

December 14, 2016 - 7 minutesmins - By Diana Kwon

News and Trends 13 Dec 2016

How Will Biotech Overcome the Huge Challenges of Microbial Resistance?

The emergence of multi-drug resistant pathogens is alarming the scientific community since their growth is increasing at an incredibly fast pace. We gathered a group of experts to discuss how biotech is addressing this pressing concern and what the next big thing will be in the field of antimicrobial resistance. Achim Plum, CCO of Curetis, highlighted that […]

December 13, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 13 Dec 2016

European Pharma closes 2016 by launching new Biotech Startups

Big pharma is already head on starting 2017 with a bang. Pfizer and Bayer are launching US-based startups in oncolytic virus and stem cell therapies. Pharma is wrapping up 2016 by investing in a pair of new ventures. Bayer and Versant have invested $225M to launch BlueRock Therapeutics, which will focus on CNS and cardiovascular diseases. This comes […]

December 13, 2016 - 2 minutesmins - By Evelyn Warner

News and Trends 12 Dec 2016

French Biotech Puts a New Lyme Disease Vaccine on the Horizon

There is currently no vaccine for the fast-growing disease in the US, & treatments cost over $1Bn every year. Valneva might have a vaccine to stem the tide. Valneva, a commercial-stage biotech based in Lyon, France, has just received clearance from the FDA and its European counterpart to begin clinical trials for its experimental Lyme Disease […]

December 12, 2016 - 2 minutesmins - By Evelyn Warner

photanol cyanobacteria platform synbio bioplastics

News and Trends 12 Dec 2016

Meet Photanol: Harnessing Cyanobacteria’s Powers for Green Chemicals

Producing fuels and chemicals from CO2 and light has long been a dream of Biotech, and Amsterdam-based Photanol is working on making it an industrial reality with engineered cyanobacteria. I had a chat with Ross Gordon, Director of Business Development, about Photanol’s strategy. Photanol was present at the latest European Bioplastics Conference to present how it uses cyanobacteria, […]

December 12, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 12 Dec 2016

A New Antibiotic from Your Nose! Thanks to Functional Genomics

Could your nose lead to major discoveries in antibiotic production? Genome mining of nose bacteria has revealed a new powerful antibiotic. Functional genomics offers a powerful tool for the isolation and detection of novel antibiotics, as the data obtained from it can be used to describe gene functions and interactions. The human microbiome has been largely […]

December 12, 2016 - 2 minutesmins - By Joachim Eeckhout

News and Trends 12 Dec 2016

With a new €120M Infusion, Pocket NGS CEO talks Success and Strategy

Seeking to disrupt the NGS market, Oxford Nanopore is rolling in cash. Before we heard the news, we sat down with CEO Gordon Sanghera to talk about the company’s success. December has been a stellar month for Oxford Nanopore. Just over a week ago, Oxford Nanopore’s MinION device was used to sequence the whole genome of a number […]

December 12, 2016 - 9 minutesmins - By Evelyn Warner

Resources

Categories

The twelve hottest biotech companies in the Boston area

Biotech bankruptcies: what to expect in 2024 following a record year?

Approaches

Therapeutic areas

RNA editing set to take off: could it outperform gene editing?

Future of cancer treatment: what will therapy look like in 2034?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The twelve hottest biotech companies in the Boston area

Biotech bankruptcies: what to expect in 2024 following a record year?

RNA editing set to take off: could it outperform gene editing?

Future of cancer treatment: what will therapy look like in 2034?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

News and Trends

10 Awesome Biotech Gifts for you and your Geekiest Loved Ones

Deloitte’s Message to Pharma: Learn from Biotech or Perish

Liquid Biopsies: Lowering the Defenses of Resistant Lung Cancer

Swedish Therapy targeting All Solid Tumors enrolls First Patient

UPDATE: Bayer seals deal with Monsanto in Dark Side slide

What do the CAR-T Patient Deaths Mean for the Future of the Field?

How Will Biotech Overcome the Huge Challenges of Microbial Resistance?

European Pharma closes 2016 by launching new Biotech Startups

French Biotech Puts a New Lyme Disease Vaccine on the Horizon

Meet Photanol: Harnessing Cyanobacteria’s Powers for Green Chemicals

A New Antibiotic from Your Nose! Thanks to Functional Genomics

With a new €120M Infusion, Pocket NGS CEO talks Success and Strategy

Subscribe to our newsletter to get the latest biotech news!